Viridian Therapeutics, Inc.\DE (VRDN) Cash & Current Investments (2013 - 2026)
Viridian Therapeutics, Inc.\DE (VRDN) recorded Cash & Current Investments of $981.53 million in Q2 2026, up 74.2% from $563.36 million a year earlier and up 28.8% from the prior quarter.
Powered by 
Analysis
Viridian Therapeutics, Inc.\DE (VRDN) Cash & Current Investments (2013 - 2026) Analysis & Trends
At the end of FY2025, Viridian Therapeutics, Inc.\DE reported Cash & Current Investments of $874.65 million, up 21.9% from FY2024.
- Annual Cash & Current Investments has increased for six straight years, with a five-year compound annual growth rate of 47.0% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $717.58 million in FY2024 (+50.3%), $477.37 million in FY2023 (+12.4%), $424.55 million in FY2022 (+115.5%) and $196.97 million in FY2021 (+54.3%).
- The Q2 2026 figure is the highest quarterly Cash & Current Investments in data going back to Q2 2013.
- On a year-over-year basis, Cash & Current Investments has increased for three consecutive quarters, with growth averaging 34.3% over the last eight quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 610.8% in Q3 2021, against a decline of 34.8% in Q3 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $762.18 million (Q1 2026), $874.65 million (Q4 2025) and $490.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Viridian Therapeutics, Inc.\DE | 2.53 Bn | -576.12 Mn | - | 981.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 981.53 Mn |
| Mar 31, 2026 | 762.18 Mn |
| Dec 31, 2025 | 874.65 Mn |
| Sep 30, 2025 | 490.90 Mn |
| Jun 30, 2025 | 563.36 Mn |
| Mar 31, 2025 | 636.63 Mn |
| Dec 31, 2024 | 717.58 Mn |
| Sep 30, 2024 | 753.24 Mn |
| Jun 30, 2024 | 571.37 Mn |
| Mar 31, 2024 | 613.19 Mn |
| Dec 31, 2023 | 477.37 Mn |
| Sep 30, 2023 | 313.01 Mn |
| Jun 30, 2023 | 334.29 Mn |
| Mar 31, 2023 | 373.86 Mn |
| Dec 31, 2022 | 424.55 Mn |
| Sep 30, 2022 | 431.32 Mn |
| Jun 30, 2022 | 161.21 Mn |
| Mar 31, 2022 | 175.43 Mn |
| Dec 31, 2021 | 196.97 Mn |
| Sep 30, 2021 | 213.81 Mn |
API Access
Viridian Therapeutics, Inc.\DE Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VRDN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "VRDN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=VRDN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();